Medicare Enrolled

Dr. Sarah Standel, PA-C

Medical Physician Assistant · Newport Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1401 AVOCADO AVE, Newport Beach, CA 92660
9497516683
In practice since 2015 (10 years)
NPI: 1962887703 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Standel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Standel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Standel

Dr. Sarah Standel is a medical physician assistant in Newport Beach, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Standel performed 779 Medicare services across 435 unique beneficiaries.

Between the years covered by Open Payments, Dr. Standel received a total of $2,423 from 22 pharmaceutical and/or device companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Standel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 20% volume in CA $2,423 industry payments

Medicare Practice Summary

Medicare Utilization ↗
779
Medicare services
Top 20% in CA for medical physician assistant
435
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~78 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
320 $5 $35
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
157 $62 $128
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
79 $35 $148
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
74 $86 $186
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
48 $63 $177
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $41 $78
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $76 $191
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $68 $193
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
16 $124 $460
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,423
Total received (2021-2024)
Avg $606/year across 4 years
Top 19% in CA for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
82
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,334 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,612
2023
$366
2022
$218
2021
$227

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$211
Lilly USA, LLC
$177
E.R. Squibb & Sons, L.L.C.
$166
Ortho Dermatologics, a division of Bausch Health US, LLC
$150
Incyte Corporation
$145
Arcutis Biotherapeutics, Inc.
$138
Janssen Biotech, Inc.
$89
Regeneron Healthcare Solutions, Inc.
$86
Amgen Inc.
$86
Biofrontera Inc.
$86
Almirall LLC
$69
Dermavant Sciences, Inc.
$52
ABBVIE INC.
$36
Novartis Pharmaceuticals Corporation
$34
PFIZER INC.
$31
LEO Pharma Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Top 3 companies account for 34.4% of 2024 payments
All-time payments by company (2021-2024) ›
Lilly USA, LLC
$218
UCB, Inc.
$211
Amgen Inc.
$203
Janssen Biotech, Inc.
$193
E.R. Squibb & Sons, L.L.C.
$188
Arcutis Biotherapeutics, Inc.
$175
Incyte Corporation
$164
Ortho Dermatologics, a division of Bausch Health US, LLC
$150
Almirall LLC
$135
Biofrontera Inc.
$125
GENZYME CORPORATION
$112
Regeneron Healthcare Solutions, Inc.
$104
PFIZER INC.
$101
Novartis Pharmaceuticals Corporation
$79
Dermavant Sciences, Inc.
$70
Sun Pharmaceutical Industries Inc.
$51
ABBVIE INC.
$36
LEO Pharma Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Solta Medical, a division of Bausch Health US, LLC
$21
Galderma Laboratories, L.P.
$16
VYNE Pharmaceuticals Inc.
$15
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · Bimzelx · COSENTYX · Clear & Brilliant · DUPIXENT · EUCRISA · Klisyri · OLUMIANT · OPZELURA · Otezla · REMICADE · SILIQ · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a medical physician assistant in Newport Beach?
Compare medical physician assistants in the Newport Beach area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
441
Per 100K population
13.9
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Standel is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 19% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Standel experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Standel performed 320 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Standel receive payments from pharmaceutical companies?
Yes. Dr. Standel received a total of $2,423 from 22 companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Standel's costs compare to other medical physician assistants in Newport Beach?
Dr. Standel's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Standel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →